Education
About Us
Working with TipRanks
Follow Us
Filana Therapeutics, Inc. (FLNA)
NASDAQ:FLNA
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ -89.42M | $ -68.03M | $ 0.00 |
| Operating Income | $ -95.39M | $ -141.45M | $ -105.96M | $ -80.02M | $ -32.87M |
| EBITDA | $ -95.39M | $ -141.15M | $ -104.43M | $ -78.72M | $ -32.33M |
| Net Income | $ -90.97M | $ -24.34M | $ -97.22M | $ -76.25M | $ -32.38M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 95.50M | $ 128.57M | $ 121.14M | $ 201.01M | $ 233.44M |
| Total Assets | $ 118.36M | $ 157.53M | $ 151.66M | $ 234.83M | $ 266.78M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 139.00K | $ 236.00K |
| Net Debt | $ -95.50M | $ -128.57M | $ -121.14M | $ -200.88M | $ -233.20M |
| Total Liabilities | $ 43.95M | $ 11.83M | $ 14.20M | $ 7.29M | $ 12.87M |
| Stockholders' Equity | $ 74.40M | $ 145.70M | $ 137.47M | $ 227.54M | $ 253.91M |
| Cash Flow | |||||
| Free Cash Flow | $ -32.83M | $ -117.03M | $ -82.44M | $ -80.23M | $ -52.41M |
| Operating Cash Flow | $ -32.25M | $ -116.93M | $ -82.03M | $ -77.51M | $ -30.20M |
| Investing Cash Flow | $ -581.00K | $ -103.00K | $ -414.00K | $ -2.71M | $ -22.21M |
| Financing Cash Flow | $ -239.00K | $ 124.47M | $ 2.56M | $ 47.80M | $ 192.34M |